Allegion 10-Q 2022-09-30
Filed 2022-10-27. 7 sections, 175K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________
FORM 10-Q
_______________________________
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2022
or
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 001-35971
_______________________________

ALLEGION PUBLIC LIMITED COMPANY
(Exact name of registrant as specified in its charter)
_______________________________
| Ireland | 98-1108930 | ||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Block D
Iveagh Court
Harcourt Road
Dublin 2, D02 VH94, Ireland
(Address of principal executive offices, including zip code)
+(353) (1) 2546200
(Registrant’s telephone number, including area code)
_______________________________
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol | Name of exchange on which registered | ||||||
| Ordinary shares, par value $0.01 per share | ALLE | New York Stock Exchange | ||||||
| 3.500% Senior Notes due 2029 | ALLE 3 ½ | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☒ | Accelerated filer | ☐ | |||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||||||||||
| Emerging growth company | ☐ | |||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The number of ordinary shares outstanding of Allegion plc as of October 24, 2022 was 87,844,822.
ALLEGION PLC
FORM 10-Q
INDEX
PART I-FINANCIAL INFORMATION
Item 1. Financial Statements
Allegion plc
Condensed and Consolidated Statements of Comprehensive Income
(Unaudited)
| Three months ended | Nine months ended | ||||||||||||||||||||||
| September 30, | September 30, | ||||||||||||||||||||||
| In millions, except per share amounts | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
| Net revenues | $ | 913.7 | $ | 717.0 | $ | 2,410.4 | $ | 2,158.2 | |||||||||||||||
| Cost of goods sold | 545.7 | 416.5 | 1,438.7 | 1,239.8 | |||||||||||||||||||
| Selling and administrative expenses | 205.1 | 162.1 | 544.7 | 503.3 | |||||||||||||||||||
| Operating income | 162.9 | 138.4 | 427.0 | 415.1 | |||||||||||||||||||
| Interest expense | 23.1 | 12.3 | 52.2 | 37.0 | |||||||||||||||||||
| Loss on divestitures | 7.6 | — | 7.6 | — | |||||||||||||||||||
| Other income, net | (1.5) | (14.7) | (7.1) | (21.4) | |||||||||||||||||||
| Earnings before income taxes | 133.7 | 140.8 | 374.3 | 399.5 | |||||||||||||||||||
| Provision for (benefit from) income taxes | 19.1 | (2.8) | 51.4 | 28.9 | |||||||||||||||||||
| Net earnings | 114.6 | 143.6 | 322.9 | 370.6 | |||||||||||||||||||
| Less: Net earnings attributable to noncontrolling interests | — | 0.1 | 0.2 | 0.4 | |||||||||||||||||||
| Net earnings attributable to Allegion plc | $ | 114.6 | $ | 143.5 | $ | 322.7 | $ | 370.2 | |||||||||||||||
| Earnings per share attributable to Allegion plc ordinary shareholders: | |||||||||||||||||||||||
| Basic net earnings | $ | 1.30 | $ | 1.60 | $ | 3.67 | $ | 4.11 | |||||||||||||||
| Diluted net earnings | $ | 1.30 | $ | 1.59 | $ | 3.65 | $ | 4.08 | |||||||||||||||
| Weighted-average shares outstanding: | |||||||||||||||||||||||
| Basic | 87.9 | 89.7 | 88.0 | 90.1 | |||||||||||||||||||
| Diluted | 88.2 | 90.3 | 88.4 | 90.7 | |||||||||||||||||||
| Total comprehensive income | $ | 46.3 | $ | 121.2 | $ | 183.8 | $ | 326.7 | |||||||||||||||
| Less: Total comprehensive (loss) income attributable to noncontrolling interests | (0.4) | — | (0.8) | 0.4 | |||||||||||||||||||
| Total comprehensive income attributable to Allegion plc | $ | 46.7 | $ | 121.2 | $ | 184.6 | $ | 326.3 |
See accompanying notes to condensed and consolidated financial statements.
Allegion plc
Condensed and Consolidated Balance Sheets
(Unaudited)
| In millions, except share amounts | September 30, 2022 | December 31, 2021 | |||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 282.2 | $ | 397.9 | |||||||
| Accounts and notes receivable, net | 422.5 | 283.3 | |||||||||
| Inventories | 477.9 | 380.4 | |||||||||
| Other current assets | 53.3 | 56.0 | |||||||||
| Total current assets | 1,235.9 | 1,117.6 | |||||||||
| Property, plant and equipment, net | 290.7 | 283.7 | |||||||||
| Goodwill | 1,373.5 | 803.8 | |||||||||
| Intangible assets, net | 599.7 | 447.5 | |||||||||
| Other noncurrent assets | 443.5 | 398.4 | |||||||||
| Total assets | $ | 3,943.3 | $ | 3,051.0 | |||||||
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 266.4 | $ | 259.1 | |||||||
| Accrued expenses and other current liabilities | 410.2 | 329.5 | |||||||||
| Short-term borrowings and current maturities of long-term debt | 12.6 | 12.6 | |||||||||
| Total current liabilities | 689.2 | 601.2 | |||||||||
| Long-term debt | 2,214.5 | 1,429.5 | |||||||||
| Other noncurrent liabilities | 246.0 | 257.9 | |||||||||
| Total liabilities | 3,149.7 | 2,288.6 | |||||||||
| Equity: | |||||||||||
| Allegion plc shareholders’ equity: | |||||||||||
| Ordinary shares, $0.01 par value (87,844,572 and 88,215,625 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively) | 0.9 | 0.9 | |||||||||
| Capital in excess of par value | 9.2 | — | |||||||||
| Retained earnings | 1,113.7 | 952.6 | |||||||||
| Accumulated other comprehensive loss | (332.5) | (194.4) | |||||||||
| Total Allegion plc shareholders’ equity | 791.3 | 759.1 | |||||||||
| Noncontrolling interests | 2.3 | 3.3 | |||||||||
| Total equity | 793.6 | 762.4 | |||||||||
| Total liabilities and equity | $ | 3,943.3 | $ | 3,051.0 |
See accompanying notes to condensed and consolidated financial statements.
Allegion plc
Condensed and Consolidated Statements of Cash Flows
(Unaudited)
| Nine months ended | |||||||||||
| September 30, | |||||||||||
| In millions | 2022 | 2021 | |||||||||
| Cash flows from operating activities: | |||||||||||
| Net earnings | $ | 322.9 | $ | 370.6 | |||||||
| Adjustments to arrive at net cash provided by operating activities: | |||||||||||
| Depreciation and amortization | 69.6 | 62.0 | |||||||||
| Loss on divestitures | 7.1 | — | |||||||||
| Changes in assets and liabilities and other non-cash items | (132.5) | (76.2) | |||||||||
| Net cash provided by operating activities | 267.1 | 356.4 | |||||||||
| Cash flows from investing activities: | |||||||||||
| Capital expenditures | (41.5) | (28.7) | |||||||||
| Acquisition of and equity investments in businesses, net of cash acquired | (923.1) | (6.5) | |||||||||
| Proceeds from sale of equity method investment | — | 7.6 | |||||||||
| Other investing activities, net | (1.3) | 12.7 | |||||||||
| Net cash used in investing activities | (965.9) | (14.9) | |||||||||
| Cash flows from financing activities: | |||||||||||
| Debt repayments, net | (9.4 |
Showing the first 8K of 90K characters. Open the full section
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from the results discussed in the forward-looking statements. Factors that may cause a difference include, but are not limited to, those discussed under Part I, Item 1A – Risk Factors in the Annual Report on Form 10-K for the fiscal year ended December 31, 2021. The following section is qualified in its entirety by the more detailed information, including our Condensed and Consolidated Financial Statements and the notes thereto, which appears elsewhere in this Quarterly Report.
Overview
Organization
Allegion plc and its consolidated subsidiaries ("Allegion," "the Company", "we," "our," or "us") is a leading global provider of security products and solutions operating in two segments: Allegion Americas and Allegion International. We sell a wide range of security products and solutions for end-users in commercial, institutional and residential facilities worldwide, including the education, healthcare, government, hospitality, commercial office and single and multi-family residential markets. Our leading brands include CISA®, Interflex®, LCN®, Schlage®, SimonsVoss® and Von Duprin®.
Recent Developments
Industry Trends and Outlook
Throughout the current year, we have seen strong demand for our products and services, particularly non-residential products in our Allegion Americas segment. Our ability to meet this elevated level of customer demand improved throughout the year, due in part to our previous actions to mitigate industry-wide supply-chain challenges (particularly shortages of electronic components), as well as improving availability of non-electronic parts and materials.
Additionally, in an effort to combat the persistent, elevated levels of inflation, we have implemented a series of pricing initiatives across our global businesses. These initiatives have resulted in strong pricing momentum which we expect to continue to contribute to revenue growth and offset the impact of inflation throughout the remainder of 2022.
In spite of these positive factors, supply chain challenges around the availability of electronic parts and components persist, and continue to negatively impact our ability to meet the elevated levels of demand for our connected electronic security products. Labor availability also continues to impact our operational efficiency. Additionally, we have experienced a further softening of demand throughout many of the Eurozone economies, impacting several of our businesses in our Allegion International segment.
We remain focused on providing exceptional service and innovation to our customers. We are beginning to realize the benefits from the measures we have taken to mitigate operational and distribution inefficiencies, such as re-engineering product designs and configurations to accept alternate electronic components and developing alternate sources of supply. We continue to invest in business initiatives to drive future growth and add value through seamless access and will continue to explore various options to control costs and enhance financial performance while minimizing disruption to customers and our overall business.
The on-going COVID-19 pandemic and the macroeconomic uncertainties noted above will likely continue to affect us in numerous and evolving ways. The full impact of these uncertainties on our business will continue to depend on future developments that we may not be able to accurately predict. These uncertainties and their potential or heightened impact on our business, results of operations, financial condition and cash flows, as well as other challenges and uncertainties that could affect our businesses are described further under Part I, Item 1A. "Risk Factors" contained in our Annual Report on Form 10-K for the year ended December 31, 2021.
Acquisition of the Access Technologies business
On July 5, 2022, we completed the acquisition of the Access Technologies business for a closing purchase price of $923.1 million. This acquisition was financed by the net proceeds from the issuance of our 5.411% Senior Notes, together with borrowings under our 2021 Revolving Facility and cash on hand. The Access Technologies business has been integrated into our Allegion Americas segment.
The Access Technologies business is a leading manufacturer, installer and service provider of automatic doors in North America, primarily in the U.S. and Canada. Its diversified customer base centers on non-residential settings, including retail, healthcare, education, commercial offices, hospitality and government. This acquisition helps us create a more comprehensive portfolio of access solutions, with the addition of automated entrances. Additionally, the Access Technologies business adds an expansive service and support network throughout the U.S. and Canada, broadening our solutions to national, regional and local customers, and complementing our existing strengths in these non-residential markets. The Access Technologies business generated $88.7 million in Net revenues during the third quarter.
Divestiture of Milre
In September 2022, we sold Milre Systek Co. Ltd. ("Milre") in South Korea for an immaterial amount. As a result of the sale, we recorded a net loss on divestiture of $7.6 million.
2022 Dividends and Share Repurchases
During the nine months ended September 30, 2022, we paid dividends of $1.23 per ordinary share to shareholders and repurchased approximately 0.5 million shares for $61.0 million.
Results of Operations – Three months ended September 30
| In millions, except per share amounts | 2022 | % of revenues | 2021 | % of revenues | |||||||||||||||||||
| Net revenues | $ | 913.7 | $ | 717.0 | |||||||||||||||||||
| Cost of goods sold | 545.7 | 59.7 | % | 416.5 | 58.1 | % | |||||||||||||||||
| Selling and administrative expenses | 205.1 | 22.4 | % | 162.1 | 22.6 | % | |||||||||||||||||
| Operating income | 162.9 | 17.8 | % | 138.4 | 19.3 | % | |||||||||||||||||
| Interest expense | 23.1 | 12.3 | |||||||||||||||||||||
| Loss on divestitures | 7.6 | — | |||||||||||||||||||||
| Other income, net | (1.5) | (14.7) | |||||||||||||||||||||
| Earnings before income taxes | 133.7 | 140.8 | |||||||||||||||||||||
| Provision for (benefit from) income taxes | 19.1 | (2.8) | |||||||||||||||||||||
| Net earnings | 114.6 | 143.6 | |||||||||||||||||||||
| Less: Net earnings attributable to noncontrolling interests | — | 0.1 | |||||||||||||||||||||
| Net earnings attributable to Allegion plc | $ | 114.6 | $ | 143.5 | |||||||||||||||||||
| Diluted net earnings per ordinary share attributable to Allegion plc ordinary shareholders: | $ | 1.30 | $ | 1.59 |
The discussions that follow describe the significant factors contributing to the changes in our results of operations for the periods presen
Showing the first 8K of 68K characters. Open the full section
Item 3. Quantitative and Qualitative Disclosures about Market Risk
There have been no material changes in our exposure to market risk during the third quarter of 2022. For a discussion of the Company’s exposure to market risk, refer to Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.
Item 4. Controls and Procedures
The Company’s management, including its Chief Executive Officer and Chief Financial Officer, have conducted an evaluation of the effectiveness of disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act)), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded as of September 30, 2022, that the disclosure controls and procedures are effective in ensuring that all material information required to be filed in this Quarterly Report on Form 10-Q has been recorded, processed, summarized and reported when required and the information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
There have not been any changes in the Company’s internal control over financial reporting that occurred during the third quarter of 2022 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II – OTHER INFORMATION
Item 1 – Legal Proceedings
In the normal course of business, we are involved in a variety of lawsuits, claims and legal proceedings, including commercial and contract disputes, labor and employment matters, product liability claims, environmental liabilities, antitrust and trade regulation matters, intellectual property disputes and tax-related matters. In our opinion, pending legal matters are not expected to have a material adverse impact on our results of operations, financial condition, liquidity or cash flows.
Item 1A. Risk Factors
There have been no material changes to our risk factors contained in our Annual Report on Form 10-K for the period ended December 31, 2021. For a further discussion of our Risk Factors, refer to the “Risk Factors” discussion contained in our Annual Report on Form 10-K for the year ended December 31, 2021.
Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
| Period | Total number of shares purchased (000s) | Average price paid per share | Total number of shares purchased as part of the 2020 Share Repurchase Authorization (000s) | Approximate dollar value of shares still available to be purchased under the 2020 Share Repurchase Authorization (000s) | ||||||||||||||||||||||
| July 1 - July 31 | — | $ | — | — | $ | 140,454 | ||||||||||||||||||||
| August 1 - August 31 | — | — | — | 140,454 | ||||||||||||||||||||||
| September 1 - September 30 | — | — | — | 140,454 | ||||||||||||||||||||||
| Total | — | $ | — | — | $ | 140,454 |
On February 6, 2020, our Board of Directors approved a share repurchase authorization of up to, and including, $800 million of the Company’s ordinary shares (the "2020 Share Repurchase Authorization"). The 2020 Share Repurchase Authorization does not have a prescribed expiration date. Based on market conditions, share repurchases are made from time to time in the open market at the discretion of management.
Item 6. Exhibits
(a) Exhibits
| Exhibit No. | Description | Method of Filing | ||||||||||||
| 3.1 | Amended and restated Memorandum and Articles of Association of Allegion plc. | Incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed with the SEC on June 13, 2016 (File No. 001-35971). | ||||||||||||
| 10.1 | John H. Stone Restricted Stock Unit Award Agreement dated August 1, 2022.* | Filed herewith. | ||||||||||||
| 10.2 | John H. Stone Stock Option Award Agreement dated August 1, 2022.* | Filed herewith. | ||||||||||||
| 31.1 | Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) or Rule 15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | Filed herewith. | ||||||||||||
| 31.2 | Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) or Rule 15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | Filed herewith. | ||||||||||||
| 32.1 | Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | Furnished herewith. | ||||||||||||
| 101.INS | XBRL Instance Document. | The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||||||||||
| 101.SCH | XBRL Taxonomy Extension Schema Document. | Filed herewith. | ||||||||||||
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document. | Filed herewith. | ||||||||||||
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document. | Filed herewith. | ||||||||||||
| 101.LAB | XBRL Taxonomy Extension Labels Linkbase Document. | Filed herewith. | ||||||||||||
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document. | Filed herewith. | ||||||||||||
| 104 | Cover Page Interactive Data File. | Formatted as Inline XBRL and contained in Exhibit 101. | ||||||||||||
| * Compensatory plan or arrangement. |
ALLEGION PLC
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| ALLEGION PLC (Registrant) | ||||||||
| Date: | October 27, 2022 | /s/ Michael J. Wagnes | ||||||
| Michael J. Wagnes, Senior Vice President and Chief Financial Officer Principal Financial Officer | ||||||||
| Date: | October 27, 2022 | /s/ Nickolas A. Musial | ||||||
| Nickolas A. Musial, Vice President, Controller and Chief Accounting Officer Principal Accounting Officer |